Marksans Pharma’s subsidiary -- Time-Cap Laboratories Inc has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its manufacturing facility located at Michael Avenue, Farmingdale, New York, USA. Current Good Manufacturing Practices (cGMP) inspection was conducted by the USFDA from April 16, 2025 to April 24, 2025.
Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.00 |
| Dr. Reddys Lab | 1227.00 |
| Cipla | 1238.90 |
| Zydus Lifesciences | 943.65 |
| Lupin | 2310.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: